Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis
- 30 June 1993
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 1 (2), 101-108
- https://doi.org/10.1016/0966-3274(93)90002-p
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tissue‐specific and allelic expression of the complement regulator CD46 is controlled by alternative splicingEuropean Journal of Immunology, 1992
- Presence of Human Chromosome 1 with Expression of Human Decay‐Accelerating Factor (DAF) Prevents Lysis of Mouse/Human Hybrid Cells by Human ComplementScandinavian Journal of Immunology, 1991
- Identification of four different CD46 (MCP) molecules with anti-peptide antibodiesBiochemical and Biophysical Research Communications, 1991
- INHIBITION OF COMPLEMENT-MEDIATED ENDOTHELIAL CELL CYTOTOXICITY BY DECAY-ACCELERATING FACTORTransplantation, 1991
- Revisiting a challenge in transplantation: Discordant xenograftingHuman Immunology, 1991
- Transfection of human CD59 complementary DNA into rat cells confers resistance to human complementEuropean Journal of Immunology, 1991
- Transplantation of discordant xenografts: a review of progressImmunology Today, 1990
- XENOGENEIC TRANSPLANTATIONTransplantation, 1988
- Hu Ly-m5: A unique antigen physically associated with HLA moleculesHuman Immunology, 1983
- EFFECT OF COBRA VENOM-INDUCED INHIBITION OF COMPLEMENT ACTIVITY ON ALLOGRAFT AND XENOGRAFT REJECTION REACTIONS1Transplantation, 1967